Literature DB >> 11401860

Characterization of a novel 132-bp exon of the human maxi-K channel.

V P Korovkina1, D J Fergus, A J Holdiman, S K England.   

Abstract

The large-conductance Ca2+-activated voltage-dependent K+ channel (maxi-K channel) induces a significant repolarizing current that buffers cell excitability. This channel can derive its diversity by alternative splicing of its transcript-producing isoforms that differ in their sensitivity to voltage and intracellular Ca2+. We have identified a novel 132-bp exon of the maxi-K channel from human myometrial cells that encodes 44 amino acids within the first intracellular loop of the channel protein. Distribution analysis reveals that this exon is expressed predominantly in human smooth muscle tissues with the highest abundance in the uterus and aorta and resembles the previously reported distribution of the total maxi-K channel transcript. Single-channel K+ current measurements in fibroblasts transfected with the maxi-K channel containing this novel 132-bp exon demonstrate that the presence of this insert attenuates the sensitivity to voltage and intracellular Ca2+. Alternative splicing to introduce this 132-bp exon into the maxi-K channel may elicit another mode to modulate cell excitability.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401860     DOI: 10.1152/ajpcell.2001.281.1.C361

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  16 in total

1.  Functional characterization of large conductance calcium-activated K+ channel openers in bladder and vascular smooth muscle.

Authors:  John Malysz; Steven A Buckner; Anthony V Daza; Ivan Milicic; Arturo Perez-Medrano; Murali Gopalakrishnan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-17       Impact factor: 3.000

2.  Expression of BK-type calcium-activated potassium channel splice variants during chick cochlear development.

Authors:  Jung-Min Kim; Ryan Beyer; Marti Morales; Stephanie Chen; Li Qian Liu; R Keith Duncan
Journal:  J Comp Neurol       Date:  2010-07-01       Impact factor: 3.215

3.  Differential trafficking of carboxyl isoforms of Ca2+-gated (Slo1) potassium channels.

Authors:  Donghui Ma; Takahiro Nakata; Guangping Zhang; Toshinori Hoshi; Min Li; Sojin Shikano
Journal:  FEBS Lett       Date:  2007-02-07       Impact factor: 4.124

Review 4.  The maxi K+ channel of human myometrium reveals a split personality.

Authors:  Edward G Moczydlowski
Journal:  J Physiol       Date:  2006-03-16       Impact factor: 5.182

5.  Translocation of an endoproteolytically cleaved maxi-K channel isoform: mechanisms to induce human myometrial cell repolarization.

Authors:  Victoria P Korovkina; Adam M Brainard; Sarah K England
Journal:  J Physiol       Date:  2006-03-09       Impact factor: 5.182

Review 6.  Potassium channels and uterine function.

Authors:  Adam M Brainard; Victoria P Korovkina; Sarah K England
Journal:  Semin Cell Dev Biol       Date:  2007-05-24       Impact factor: 7.727

Review 7.  Control of alternative pre-mRNA splicing by Ca(++) signals.

Authors:  Jiuyong Xie
Journal:  Biochim Biophys Acta       Date:  2008-01-17

8.  Diabetes-induced changes in the alternative splicing of the slo gene in corporal tissue.

Authors:  Kelvin P Davies; Weixin Zhao; Moses Tar; Johanna C Figueroa; Pratik Desai; Vytas K Verselis; Jack Kronengold; Hong-Zhan Wang; Arnold Melman; George J Christ
Journal:  Eur Urol       Date:  2006-11-20       Impact factor: 20.096

9.  Ageing causes cytoplasmic retention of MaxiK channels in rat corporal smooth muscle cells.

Authors:  K P Davies; Y Stanevsky; M T Tar; T Moses; J S Chang; M R Chance; A Melman
Journal:  Int J Impot Res       Date:  2007-02-08       Impact factor: 2.896

10.  Nardilysin convertase regulates the function of the maxi-K channel isoform mK44 in human myometrium.

Authors:  Victoria P Korovkina; Susan J Stamnes; Adam M Brainard; Sarah K England
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-31       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.